2010
DOI: 10.1016/j.exer.2010.03.021
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of Autofluorescent retinal images and measurement of atrophic lesion growth in Stargardt disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
63
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(69 citation statements)
references
References 33 publications
6
63
0
Order By: Relevance
“…Decreased FAF is a commonly used marker of retinal degeneration in ABCA4 retinopathy. The estimated rates of enlargement of reduced FAF areas in nullizygous patients (1.4-1.5 mm 2 /y) were comparable with the higher end of the range reported by Chen et al (0.2-2.1 mm 2 /y), 27 the rates reported for similar FAF patterns (0.7-4.4 mm 2 /y), 28 and the rates reported for ERG group 3 (2.3 mm 2 /y), 29 highlighting the utility of this parameter for assessing progressive maculopathy in ABCA4-retinopathy. The estimated rates of progression for p.G1961E patients were significantly slower (0.03-0.06 mm 2 /y), highlighting the importance of considering the genotype in future clinical studies, especially involving patients with otherwise overlapping characteristics (e.g., early disease onset).…”
Section: Discussionsupporting
confidence: 74%
“…Decreased FAF is a commonly used marker of retinal degeneration in ABCA4 retinopathy. The estimated rates of enlargement of reduced FAF areas in nullizygous patients (1.4-1.5 mm 2 /y) were comparable with the higher end of the range reported by Chen et al (0.2-2.1 mm 2 /y), 27 the rates reported for similar FAF patterns (0.7-4.4 mm 2 /y), 28 and the rates reported for ERG group 3 (2.3 mm 2 /y), 29 highlighting the utility of this parameter for assessing progressive maculopathy in ABCA4-retinopathy. The estimated rates of progression for p.G1961E patients were significantly slower (0.03-0.06 mm 2 /y), highlighting the importance of considering the genotype in future clinical studies, especially involving patients with otherwise overlapping characteristics (e.g., early disease onset).…”
Section: Discussionsupporting
confidence: 74%
“…He reported that some cases also had macular degeneration [2,3]. Stargardt's disease and fundus flavimaculatus usually have an autosomal recessive inheritance pattern [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] and rarely an autosomal dominant pattern [17]. …”
Section: Introductionmentioning
confidence: 99%
“…Because SFF is a complex retinal dystrophy with wide variations in phenotype, it is generally diagnosed by fundus findings and fluorescein angiograms [5]. Recently, fundus autofluorescence imaging has been reported to be helpful in evaluating the status of the photoreceptors/retinal pigment epithelium in eyes with SFF [10,11,12,13,14,15,16]. Foveal sparing, which was observed by ophthalmoscopy and/or fundus autofluorescence imaging, was reported to be present in patients with slowly progressing SFF and relatively good visual acuity [11,13,14].…”
Section: Introductionmentioning
confidence: 99%
“…Patients in the third group have a poorer visual prognosis [8,16]. Blue light fundus autofluorescence aids in making a diagnosis, with hyperautofluorescence associated with increased lipofuscin accumulation at the level of the retinal pigment epithelium and hypo-autofluorescence indicating loss of retinal pigment epithelial cells [8,17,18,19,20]. Fujinami et al [21] re-examined the patients described by Lois et al [18], defined 3 autofluorescence subtypes and found an association between baseline subtype, genotype and atrophy progression.…”
mentioning
confidence: 99%